Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		12 Months Ended
		Jun. 30, 2019	Jun. 30, 2018	[1]	Jun. 30, 2017	[1]
Revenue:
Total revenue		$ 220,896	$ 218,463		$ 209,715
Cost of revenue:
Total cost of revenue		124,675	128,071		120,436
Gross profit		96,221	90,392		89,279
Operating expenses:
Research and development		83,953	85,646		67,406
Sales and marketing		19,322	20,748		21,995
General and administrative		23,811	21,562		23,041
Goodwill impairment		2,556	2,666		0
Legal settlement and contingencies		700	425		6,424
Total operating expenses		130,342	131,047		118,866
Loss from operations		(34,121)	(40,655)		(29,587)
Other income, net		2,916	833		892
Loss before provision for income taxes		(31,205)	(39,822)		(28,695)
Provision for income taxes		1,283	1,012		841
Net loss	[2]	$ (32,488)	$ (40,834)		$ (29,536)
Net loss per share, basic and diluted (in dollars per share)		$ (0.71)	$ (0.92)		$ (0.68)
Weighted average shares used in computing net loss per share, basic and diluted (in shares)		45,577	44,498		43,343
Product
Revenue:
Total revenue		$ 168,619	$ 163,599		$ 155,025
Cost of revenue:
Total cost of revenue		97,245	102,224		98,531
Services
Revenue:
Total revenue		52,277	54,864		54,690
Cost of revenue:
Total cost of revenue		$ 27,430	$ 25,847		$ 21,905

[1] See Note 1 for a summary of adjustments.

[2] See Note 1 for a summary of adjustments. The cumulative effect adjustment to Accumulated Deficit and Total Stockholders' Equity related to the adoption of ASU No. 2014-09 (Topic 606) as of June 30, 2016 was $11.8 million.